+45 33 75 10 00

info@nordic-labs.com

 
CardioMetabolic Profile (Insulin, hsCRP, HbA1c, TG, CH, LDL, HDL, VLDL)

The blood spot CardioMetabolic Profile allows early detection of major indicators associated with metabolic/insulin resistance syndrome.

970
Fasting Insulin

The Fasting Insulin bloodspot is designed to detect insulin resistance (metabolic syndrome), a sign of diabetes, pre-diabetes, and heart disease.

1696
HbA1c

The HbA1c (hemoglobin A1c) test is a blood test used to monitor the status of a patient’s diabetes.

976
Hs-CRP

The hs-CRP (High-sensitivity C-Reactive Protein) bloodspot is designed to test for risk of heart disease.

1549
LIPIDgen (12 SNPs)

This test requires a blood draw, so please ensure you can refer to a phlebotomist in the clients area before you order this test.

LipidGen is an optimised composition of gene polymorphisms pertinent to disorders of the lipid metabolism for identifying the essential genetic causes of this disorder

1775
Liposcan (HDL & LDL Subfractions)

This test requires a blood draw, so please ensure you can refer to a phlebotomist in the clients area before you order this test.

Liposcan (HDL & LDL Subfractions) is a new procedure that determines the actual heart attack risk by means of a differentiated analysis of HDL and LDL subfractions. 

1507
Oxidised LDL
This test requires a blood draw, so please ensure you can refer to a phlebotomist in the clients area before you order this test


The Oxidised LDL test is designed to detect various cardiovascular conditions including Coronary Artery Disease (CAD) and atherosclerosis.
1552
Oxidised LDL & Liposcan Panel

This panel combines both the Oxidised LDL and Liposcan tests:

 

2410
Cardiovascular Risk Profile

This test requires a blood draw, so please ensure you can refer to a phlebotomist in the clients area before you order this test.

Cardiovascular disease (CVD) is associated with more deaths than all cancers—and more deaths in women than breast cancer. The Cardiovascular Risk Profile reviews a thorough battery of biomarkers to aid in early detection and reduction of risk factors before the disease progresses.

3514